Oct. 13, 2017—Sysmex America announced the introduction of CyFlow Antibodies, a comprehensive portfolio of analyte specific reagent antibodies for use in flow cytometry applications. The Sysmex ASR portfolio includes monoclonal antibodies with high mean fluorescent intensity and dependable lot-to-lot consistency. The ASR antibody product launch marks Sysmex’s entrance into the clinical flow cytometry market.
The portfolio of Sysmex ASRs can be used on any flow cytometer platform, allowing pathology laboratories to use the clone with the highest quality, regardless of supplier, for their laboratory-developed tests.
“The new ASR reagent portfolio represents the first step for Sysmex into routine clinical flow cytometry,” Lew McAllan, senior director of clinical flow cytometry, said in a statement. “These high-quality reagents are developed under cGMP guidelines and are used in immunophenotyping. Clinical flow cytometry is a natural progression from Sysmex’s strength in hematology. With additional sample preparation and analysis products to follow, Sysmex will be well positioned to offer our customers extended hematology analysis capability. The ASRs are just the start.”